Publication stageIn Press Journal Pre-Proof
Funding: This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH) and through a Cooperative Research and Development Agreement (CRADA) between the NCI/NIH and ImmunityBio, Inc.
Disclosure: The NCI, NIH has an ongoing CRADA with ImmunityBio, Inc. CP discloses spouse’s employment and holdings in MacroGenics, Inc. All other authors from the NCI, NIH do not have competing interests to disclose.
User LicenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy